Navigation Links
Major discovery opens door to leishmania treatment
Date:10/6/2009

This release is available in French.

Leishmania is a deadly parasitic disease that affects over 12 million people worldwide, with more than 2 million new cases reported every year. Until recently, scientists were unsure exactly how the parasite survives inside human cells. That mystery has now been solved according to a new study published in Science Signaling by a team led by Dr. Martin Olivier a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC) and McGill University. It is hoped the new study will lead to the development of the first prophylactic treatment for leishmania.

Leishmania is typically a sub-tropical and tropical infectious disease transmitted through the bite of female phlebotomine sandflies. The parasites enter the bloodstream and are ingested by macrophage white blood cells where they block immune function and multiply, spreading to other tissues in the body. Leishmania can occur in cutaneous forms, which are generally curable, as well as in a more dangerous and potentially fatal visceral form.

The researchers discovered that a metalloprotease a molecule called GP63 found on the surface of the parasite, plays a role in neutralizing the macrophage's defences. "Our results demonstrate the mechanism through which the GP63 protease alters the function of the macrophages by activating its own negative regulatory mechanisms," says Dr. Olivier. "The infected cells act 'frozen', which hinders the body's innate inflammatory immune response and leads to infection."

The work is significant in that it is the first study that explains how the leishmania parasite blocks the immune function of macrophages. "Our research indicates that the GP63 protease is the target of choice for innovative future treatments, in terms of prevention," says Dr. Olivier.

The GP63 protea
'/>"/>

Contact: Julie Robert
julie.robert@muhc.mcgill.ca
514-843-1560
McGill University Health Centre
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. How mitochondrial gene defects impair respiration, other major life functions
2. BioConference Live Attracts Major Life Science Sponsors
3. Restoring a natural root signal helps to fight a major corn pest
4. Family planning a major environmental impact
5. Avoiding hysterectomy: Major interventional radiology E-collection info available
6. Researchers achieve major breakthrough with water desalination system
7. Major breakthrough in early detection and prevention of AMD
8. Researcher garners major award from NIH for further exploration into the mechanisms of obesity
9. Major funding to help cut CO2 emissions
10. Cells split personality is a major discovery into neurological diseases
11. Major international study challenges notions of how genes are controlled in mammals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2012)... gauge the toxicity of quantum dots in primates has found ... a hopeful outcome for doctors and scientists seeking new ways ... which will appear on May 20 in Nature Nanotechnology ... of quantum dots in primates. The study and information in ... at 1 p.m. U.S. Eastern Standard Time. , In the ...
(Date:5/18/2012)... the rabies virus evolves in bats may depend heavily ... researchers at the University of Georgia, the U.S. Centers ... in Belgium. Their study, published May 17 in the ... geographical location was the most accurate predictor of the ... sub-tropical bat species evolved nearly four times faster than ...
(Date:5/18/2012)... we use gasoline, diesel, plastics, rubbers, and numerous ... petrochemical refinery processes. However, this is not sustainable ... Furthermore, our world is facing problems associated with ... the increasing use of fossil resources. One solution ... renewable non-food biomass for the production of chemicals, ...
Breaking Biology News(10 mins):Good news for nanomedicine: Quantum dots appear safe in pioneering study on primates 2Hitting snooze on the molecular clock: Rabies evolves slower in hibernating bats 2Hitting snooze on the molecular clock: Rabies evolves slower in hibernating bats 3Production of chemicals without petroleum 2RIKEN and Max Planck Society establish Joint Research Center for Systems Chemical Biology 19012 1Group Health Research Institute founder Dr Ed Wagner wins William B Graham Prize 81403 1Group Health Research Institute founder Dr Ed Wagner wins William B Graham Prize 81403 2Group Health Research Institute founder Dr Ed Wagner wins William B Graham Prize 81403 3AquaStar Holdings Inc s Client Receives U S Patent 7 708 944 for Portable Capillary Sensor Technology 19261 1AquaStar Holdings Inc s Client Receives U S Patent 7 708 944 for Portable Capillary Sensor Technology 19261 2
... University researcher suggests a new avenue for developing a vaccine ... viruses. , In a study published earlier this year ... mice vaccinated with a live, genetically-modified herpes simplex virus type ... being exposed to a particularly lethal "wild-type" strain of the ...
... researcher Richard H. Ebright and his collaborators have resolved key ... subject of the 2006 Nobel Prize in Chemistry. , ... to read and carry out the out instructions contained in ... as RNA polymerase, which synthesizes an RNA copy of the ...
... at Duke University have devised a new way to ... making it useful for providing longer-lasting treatment for osteoarthritis, ... drug, which would be injected directly into arthritic joints, ... few hours the unmodified drug would last, the researchers ...
Other Biology News:Research holds promise for herpes vaccine 2Nanotech tools yield DNA transcription breakthrough 2Nanotech tools yield DNA transcription breakthrough 3Nanotech tools yield DNA transcription breakthrough 4New engineered drug may offer prolonged arthritis relief 2New engineered drug may offer prolonged arthritis relief 3New engineered drug may offer prolonged arthritis relief 4
(Date:5/15/2012)... DIEGO, May 15, 2012 Cardium Therapeutics ... its financial results for the first quarter ended ... (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ) ... 2012 financial results, Cardium reported its goals for ... and include (1) plans to advance commercialization of ...
(Date:5/15/2012)... Connecticut and SHENZHEN, China, May 15, 2012 ... organizations, announced today that a new Roche GS FLX+ ... Shenzhen, China. The goal is to complement the existing ... long read sequencing capability. The GS FLX+ ... features the unique combination of long reads, exceptional accuracy ...
(Date:5/14/2012)... LED light with 20 times the efficiency of an ... and store data 100 times faster than those we ... if we could turn waste heat into electricity, or ... more efficient, and more accessible? , The (IEE) ... world-ranked collaborative research campus that boasts five Nobel laureates ...
(Date:5/14/2012)... May 14, 2012  More than one billion people worldwide ... decrease in the ability of the lens in the eye ... all seen others struggle with trying to read menus and ... To combat this change in vision, which often begins around ... the choices for lenses that are both multifocal ...
Breaking Biology Technology:Cardium Presents First Quarter 2012 Financial Results and Recent Developments 2Cardium Presents First Quarter 2012 Financial Results and Recent Developments 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 4Cardium Presents First Quarter 2012 Financial Results and Recent Developments 5Cardium Presents First Quarter 2012 Financial Results and Recent Developments 6Cardium Presents First Quarter 2012 Financial Results and Recent Developments 7Cardium Presents First Quarter 2012 Financial Results and Recent Developments 8Cardium Presents First Quarter 2012 Financial Results and Recent Developments 9Cardium Presents First Quarter 2012 Financial Results and Recent Developments 10Cardium Presents First Quarter 2012 Financial Results and Recent Developments 11BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research 2BGI Installs Roche GS FLX+ System to Enhance Long Read Sequencing Capabilities for Genome and Transcriptome Research 3Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara 2Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara 3Oracle chairman Jeff Henley makes $50 million gift to UC Santa Barbara 4New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life 2New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life 3
... PARK, N.C., June 6 Quintiles,Transnational Corp. today ... FACC, as Chief Medical and Scientific Officer. Cabell,succeeds ... Vice,President, Clinical Research Strategies., As Chief Medical ... initiatives that focus on bioethics and the protection ...
... ITMN ) today announced that John Hodgman, Senior ... at the Goldman Sachs,Twenty-Ninth Annual Global Healthcare Conference in ... PDT (11:05 a.m. EDT). Mr. Hodgman will also,present at ... Technology Conference in New York on June 12, 2008 ...
... Telik, Inc.,(Nasdaq: TELK ) announced that company ... Needham & Company Biotechnology and Medical,Technology Conference in New ... Eastern time (7:00 a.m. Pacific time). A live and ... Telik website, http://www.telik.com ., Telik, Inc. of Palo ...
Other Biology Technology:Quintiles Appoints Christopher Cabell to Chief Medical and Scientific Officer 2InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences 2
mu Opioid Receptor splice variant Immunogen: Synthetic peptide corresponding to residues K S C M D R G M R N L L P D D G P R Q E of Mu Opioid Receptor. Storage: -20 C, Avoid Freeze/Thaw Cycle...
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
Sheep polyclonal to EBNA 3B ( Abpromise for all tested applications). Antigen: Full length protein....
NANS Immunogen: NANS (NP_061819, 260 a.a. ~ 360 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Biology Products: